| Year |
Citation |
Score |
| 2023 |
Kalashnikova I, Patrikeeva S, Nanovskaya TN, Andreev YA, Ahmed MS, Rytting E. Folate-mediated transport of nanoparticles across the placenta. Pharmaceutical Nanotechnology. PMID 37461351 DOI: 10.2174/2211738511666230717122429 |
0.321 |
|
| 2018 |
Ali S, Albekairi N, Wang XM, Patrikeeva S, Nanovskaya TN, Ahmed MS, Rytting E. Determination of the Transplacental Transfer of Paclitaxel and Antipyrine by High Performance Liquid Chromatography Coupled with Photodiode Array Detector. Journal of Liquid Chromatography & Related Technologies. 41: 232-238. PMID 30774296 DOI: 10.1080/10826076.2018.1436068 |
0.331 |
|
| 2018 |
Shah M, Bourner L, Ali S, Al-Enazy S, Youssef MM, Fisler M, Rytting E. HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media. Separations. 5. PMID 29984222 DOI: 10.3390/Separations5010009 |
0.422 |
|
| 2018 |
Ali S, Alenazy S, Shah M, Bourner L, Rytting E. Abstract A118: Efflux of paclitaxel nanoformulation in cell culture model of human placental barrier Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A118 |
0.409 |
|
| 2017 |
Shah M, Bourner L, Ali S, Al-Enazy S, Rytting E. Cytotoxicity of Endocytosis and Efflux Inhibitors in the BeWo Cell Line. Journal of Pharmaceutical Research International. 17. PMID 29214230 DOI: 10.9734/Jpri/2017/34606 |
0.377 |
|
| 2016 |
Fokina VM, Xu M, Rytting E, Abdel-Rahman SZ, West H, Oncken C, Clark SM, Ahmed MS, Hankins GD, Nanovskaya TN. Pharmacokinetics of bupropion and its pharmacologically active metabolites in pregnancy. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 27528039 DOI: 10.1124/Dmd.116.071530 |
0.337 |
|
| 2016 |
Al-Enazy S, Ali S, Albekairi N, El-Tawil M, Rytting E. Placental control of drug delivery. Advanced Drug Delivery Reviews. PMID 27527665 DOI: 10.1016/J.Addr.2016.08.002 |
0.396 |
|
| 2016 |
Ilekis JV, Tsilou E, Fisher S, Abrahams VM, Soares MJ, Cross JC, Zamudio S, Illsley NP, Myatt L, Colvis C, Costantine MM, Haas DM, Sadovsky Y, Weiner C, Rytting E, et al. Placental Origins of Adverse Pregnancy Outcomes: Potential Molecular Targets- An Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. American Journal of Obstetrics and Gynecology. PMID 26972897 DOI: 10.1016/J.Ajog.2016.03.001 |
0.382 |
|
| 2015 |
Albekairi NA, Al-Enazy S, Ali S, Rytting E. Transport of digoxin-loaded polymeric nanoparticles across BeWo cells, an in vitro model of human placental trophoblast. Therapeutic Delivery. 6: 1325-34. PMID 26652279 DOI: 10.4155/Tde.15.79 |
0.417 |
|
| 2015 |
Ryu RJ, Eyal S, Easterling TR, Caritis SN, Venkataraman R, Hankins G, Rytting E, Thummel K, Kelly EJ, Risler L, Phillips B, Honaker MT, Shen DD, Hebert MF. Pharmacokinetics of metoprolol during pregnancy and lactation. Journal of Clinical Pharmacology. PMID 26461463 DOI: 10.1002/Jcph.631 |
0.318 |
|
| 2015 |
Rytting E. Exploring the interactions of nanoparticles with multiple models of the maternal--fetal interface. Nanotoxicology. 9: 137-8. PMID 25923351 DOI: 10.3109/17435390.2013.877997 |
0.317 |
|
| 2015 |
Lopalco A, Ali H, Denora N, Rytting E. Oxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast. International Journal of Nanomedicine. 10: 1985-96. PMID 25792832 DOI: 10.2147/Ijn.S77498 |
0.399 |
|
| 2015 |
Poulsen MS, Mose T, Maroun LL, Mathiesen L, Knudsen LE, Rytting E. Kinetics of silica nanoparticles in the human placenta. Nanotoxicology. 9: 79-86. PMID 23742169 DOI: 10.3109/17435390.2013.812259 |
0.364 |
|
| 2014 |
Rytting E, Wang X, Vernikovskaya DI, Zhan Y, Bauer C, Abdel-Rahman SM, Ahmed MS, Nanovskaya TN. Metabolism and disposition of bupropion in pregnant baboons (Papio cynocephalus). Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 1773-9. PMID 25097227 DOI: 10.1124/Dmd.114.058255 |
0.308 |
|
| 2014 |
Ali S, Rytting E. Influences of nanomaterials on the barrier function of epithelial cells. Advances in Experimental Medicine and Biology. 811: 45-54. PMID 24683026 DOI: 10.1007/978-94-017-8739-0_3 |
0.33 |
|
| 2014 |
Mathiesen L, Mørck TA, Zuri G, Andersen MH, Pehrson C, Frederiksen M, Mose T, Rytting E, Poulsen MS, Nielsen JK, Knudsen LE. Modelling of human transplacental transport as performed in Copenhagen, Denmark Basic and Clinical Pharmacology and Toxicology. 115: 93-100. PMID 24646015 DOI: 10.1111/Bcpt.12228 |
0.41 |
|
| 2014 |
Rytting E, Nanovskaya TN, Wang X, Vernikovskaya DI, Clark SM, Cochran M, Abdel-Rahman SM, Venkataramanan R, Caritis SN, Hankins GD, Ahmed MS. Pharmacokinetics of indomethacin in pregnancy. Clinical Pharmacokinetics. 53: 545-51. PMID 24493205 DOI: 10.1007/S40262-014-0133-6 |
0.311 |
|
| 2013 |
Ali H, Kalashnikova I, White MA, Sherman M, Rytting E. Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model. International Journal of Pharmaceutics. 454: 149-57. PMID 23850397 DOI: 10.1016/J.Ijpharm.2013.07.010 |
0.417 |
|
| 2013 |
Ali H, Kilic G, Vincent K, Motamedi M, Rytting E. Nanomedicine for uterine leiomyoma therapy. Therapeutic Delivery. 4: 161-75. PMID 23343157 DOI: 10.4155/Tde.12.144 |
0.315 |
|
| 2013 |
Kalashnikova I, Rytting E. Folate-mediated transport of nanoparticles for targeted drug delivery across BeWo cells Placenta. 34. DOI: 10.1016/J.Placenta.2013.06.138 |
0.426 |
|
| 2012 |
Cartwright L, Poulsen MS, Nielsen HM, Pojana G, Knudsen LE, Saunders M, Rytting E. In vitro placental model optimization for nanoparticle transport studies. International Journal of Nanomedicine. 7: 497-510. PMID 22334780 DOI: 10.2147/Ijn.S26601 |
0.415 |
|
| 2011 |
Rytting E. Rheumatoid arthritis: Escorted for efficacy Science Translational Medicine. 3. DOI: 10.1126/Scitranslmed.3003458 |
0.323 |
|
| 2011 |
Rytting E. Nanotechnology: Helping the heart to heal Science Translational Medicine. 3. DOI: 10.1126/Scitranslmed.3003339 |
0.303 |
|
| 2011 |
Rytting E. Getting past the bullies Science Translational Medicine. 3. DOI: 10.1126/Scitranslmed.3002965 |
0.353 |
|
| 2011 |
Rytting E. Weeding the tares, sparing the wheat Science Translational Medicine. 3. DOI: 10.1126/Scitranslmed.3002721 |
0.309 |
|
| 2011 |
Rytting E. Nanoparticles and jelly Science Translational Medicine. 3. DOI: 10.1126/Scitranslmed.3002483 |
0.33 |
|
| 2010 |
Beck-Broichsitter M, Rytting E, Lebhardt T, Wang X, Kissel T. Preparation of nanoparticles by solvent displacement for drug delivery: a shift in the "ouzo region" upon drug loading. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 41: 244-53. PMID 20600881 DOI: 10.1016/J.Ejps.2010.06.007 |
0.331 |
|
| 2010 |
Mørck TJ, Sorda G, Bechi N, Rasmussen BS, Nielsen JB, Ietta F, Rytting E, Mathiesen L, Paulesu L, Knudsen LE. Placental transport and in vitro effects of Bisphenol A. Reproductive Toxicology (Elmsford, N.Y.). 30: 131-7. PMID 20214975 DOI: 10.1016/J.Reprotox.2010.02.007 |
0.404 |
|
| 2010 |
Rytting E, Bur M, Cartier R, Bouyssou T, Wang X, Krüger M, Lehr CM, Kissel T. In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 141: 101-7. PMID 19720096 DOI: 10.1016/J.Jconrel.2009.08.021 |
0.382 |
|
| 2009 |
Poulsen MS, Rytting E, Mose T, Knudsen LE. Modeling placental transport: correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion. Toxicology in Vitro : An International Journal Published in Association With Bibra. 23: 1380-6. PMID 19647068 DOI: 10.1016/J.Tiv.2009.07.028 |
0.395 |
|
| 2009 |
Mathiesen L, Rytting E, Mose T, Knudsen LE. Transport of benzo[alpha]pyrene in the dually perfused human placenta perfusion model: effect of albumin in the perfusion medium. Basic & Clinical Pharmacology & Toxicology. 105: 181-7. PMID 19508462 DOI: 10.1111/J.1742-7843.2009.00431.X |
0.402 |
|
| 2008 |
Rytting E, Nguyen J, Wang X, Kissel T. Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opinion On Drug Delivery. 5: 629-39. PMID 18532919 DOI: 10.1517/17425247.5.6.629 |
0.318 |
|
| 2008 |
Rytting E, Audus KL. Contributions of phosphorylation to regulation of OCTN2 uptake of carnitine are minimal in BeWo cells. Biochemical Pharmacology. 75: 745-51. PMID 17977516 DOI: 10.1016/J.Bcp.2007.09.015 |
0.615 |
|
| 2007 |
Rytting E, Audus KL. Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells. The Journal of Pharmacy and Pharmacology. 59: 1095-102. PMID 17725851 DOI: 10.1211/Jpp.59.8.0006 |
0.614 |
|
| 2007 |
Rytting E, Bryan J, Southard M, Audus KL. Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells. Biochemical Pharmacology. 73: 891-900. PMID 17174940 DOI: 10.1016/J.Bcp.2006.11.020 |
0.627 |
|
| 2006 |
Bode CJ, Jin H, Rytting E, Silverstein PS, Young AM, Audus KL. In vitro models for studying trophoblast transcellular transport. Methods in Molecular Medicine. 122: 225-39. PMID 16511984 DOI: 10.1385/1-59259-989-3:225 |
0.622 |
|
| 2005 |
Rytting E, Audus KL. Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells. The Journal of Pharmacology and Experimental Therapeutics. 312: 192-8. PMID 15316089 DOI: 10.1124/Jpet.104.072363 |
0.591 |
|
| 2005 |
Karunaratne DN, Silverstein PS, Vasandani V, Young AM, Rytting E, Yops B, Audus KL. Cell Culture Models for Drug Transport Studies Drug Delivery: Principles and Applications. 103-124. DOI: 10.1002/0471475734.ch7 |
0.566 |
|
| Show low-probability matches. |